0001209191-21-016972.txt : 20210303
0001209191-21-016972.hdr.sgml : 20210303
20210303170117
ACCESSION NUMBER: 0001209191-21-016972
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210301
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hayes Christopher G.
CENTRAL INDEX KEY: 0001805359
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38529
FILM NUMBER: 21710123
MAIL ADDRESS:
STREET 1: C/O VERRICA PHARMACEUTICALS INC.
STREET 2: 10 NORTH HIGH STREET, SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verrica Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660334
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463137900
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 NORTH HIGH STREET
STREET 2: SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
BUSINESS PHONE: 484-453-3300
MAIL ADDRESS:
STREET 1: 10 NORTH HIGH STREET
STREET 2: SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-01
0
0001660334
Verrica Pharmaceuticals Inc.
VRCA
0001805359
Hayes Christopher G.
C/O VERRICA PHARMACEUTICALS INC.
10 NORTH HIGH STREET, SUITE 200
WEST CHESTER
PA
19380
0
1
0
0
Chief Legal Officer
Employee Stock Option (Right to Buy)
14.32
2021-03-01
4
A
0
65000
0.00
A
2031-02-28
Common Stock
65000
65000
D
25% of the total shares subject to the option shall vest on March 1, 2022 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.
/s/ Mark Ballantyne, Attorney-in-Fact
2021-03-03